EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy

Jon Soo Kim, Won Seop Kim, Won Young Sung, Hyewon Woo

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Jon Soo Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea. Hauptthemen laut MEDLINE: Levetiracetam, Anticonvulsants, Epilepsy, Pyridones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Perampanel (PER) is expanding the therapeutic scope for pediatric epilepsy owing to its efficacy and favorable safety profile. However, concerns about psychiatric and behavioral adverse events (PBAEs) in combination therapy with levetiracetam (LEV) continue to contribute to hesitation in its prescription. We investigated the risk profiles for PBAEs when adding PER to pediatric epilepsy treatment and analyzed the differences according to the presence of concomitant LEV. METHODS: We retrospectively reviewed the medical records of children aged 4-18 years with epilepsy who were prescribed PER as adjunctive therapy from March 2016 to February 2023. We compared the occurrence and management of PBAEs between the PER without LEV and PER with LEV groups. The risk factors for PBAEs were also analyzed. RESULTS: Ninety-four patients (53 boys and 41 girls) were included in this study. The median age of total patients at the time of adding PER was 14.9 years (12.3-16.4 years), and 53 patients (56.4 %) had concomitant LEV. Forty-seven PBAEs occurred in 34 patients (36.2 %), with no significant differences depending on whether concomitant LEV is present or not. The most common PBAEs were aggression (14.9 %), irritability (9.6 %), affect lability (7.4 %), and acute psychosis (6.4 %). PBAEs occurred at a lower dosage (2-6 mg/day) in 70.6 % of the patients. In addition, 73.5 % of patients with PBAEs continued PER treatment by follow-up observation or by reducing the PER dosage. No risk factors, such as the presence of concomitant LEV or lamotrigine, any comorbid conditions, higher PER dosage (8-12 mg/day), two or more concomitant anti-seizure medications, and younger age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevetiracetamAnticonvulsantsEpilepsyPyridonesNitrilesMental DisordersDrug Therapy, CombinationHumansMaleChildFemaleAdolescentRetrospective StudiesChild, Preschool

Stichwörter der Autor:innen

Adverse eventsEpilepsyLevetiracetamPerampanelRisk factors

Substanzen

perampanelLevetiracetamAnticonvulsantsPyridonesNitriles

Autor:innen und Institutionen

  • Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea.
  • Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea; Department of Pediatrics, Chungbuk National University, College of Medicine, Cheongju, Republic of Korea.
  • Department of Emergency Medicine, Daejeon Eulji Medical Center, Eulji University, Daejeon, Republic of Korea.
  • Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea. Electronic address: hyewonwoo@gmail.com.

Zitieren

APA

Kim, J. S., Kim, W. S., Sung, W. Y., & Woo, H. (2024). Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109740

Vancouver

Kim JS, Kim WS, Sung WY, Woo H. Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109740

BibTeX
@article{Kim2024,
  author = {Kim, Jon Soo and Kim, Won Seop and Sung, Won Young and Woo, Hyewon},
  title = {Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109740}
}
Kostenlos starten →